88 related articles for article (PubMed ID: 32289340)
1. Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro.
Fallah-Mehrjardi K; Mirzaei HR; Masoumi E; Jafarzadeh L; Rostamian H; Khakpoor-Koosheh M; Alishah K; Noorbakhsh F; Hadjati J
Immunol Lett; 2020 Jul; 223():44-52. PubMed ID: 32289340
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival.
Kamai T; Kijima T; Tsuzuki T; Nukui A; Abe H; Arai K; Yoshida KI
Cancer Immunol Immunother; 2021 Jul; 70(7):2009-2021. PubMed ID: 33416945
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
[TBL] [Abstract][Full Text] [Related]
4. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract][Full Text] [Related]
5. Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia.
Cox MJ; Lucien F; Sakemura R; Boysen JC; Kim Y; Horvei P; Manriquez Roman C; Hansen MJ; Tapper EE; Siegler EL; Forsman C; Crotts SB; Schick KJ; Hefazi M; Ruff MW; Can I; Adada M; Bezerra E; Kankeu Fonkoua LA; Nevala WK; Braggio E; Ding W; Parikh SA; Kay NE; Kenderian SS
Mol Ther; 2021 Apr; 29(4):1529-1540. PubMed ID: 33388419
[TBL] [Abstract][Full Text] [Related]
6. A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis.
Lei Q; Zhen S; Zhang L; Zhao Q; Yang L; Zhang Y
Cancer Immunol Immunother; 2024 Apr; 73(6):108. PubMed ID: 38642131
[TBL] [Abstract][Full Text] [Related]
7. Unlocking antitumor immunity with adenosine receptor blockers.
Remley VA; Linden J; Bauer TW; Dimastromatteo J
Cancer Drug Resist; 2023; 6(4):748-767. PubMed ID: 38263981
[TBL] [Abstract][Full Text] [Related]
8. Subtle Structural Changes across the Boundary between A
Wang H; Yang X; Li Y; Ze S; Feng B; Weng Y; Gao A; Song G; Liu M; Xie Q; Wang Y; Lu W
J Med Chem; 2024 Mar; 67(6):5075-5092. PubMed ID: 38483150
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers.
Myojin Y; McCallen JD; Ma C; Bauer KC; Ruf B; Benmebarek MR; Green BL; Wabitsch S; McVey JC; Fu C; Xie C; Greten TF
JHEP Rep; 2024 Jan; 6(1):100959. PubMed ID: 38192537
[TBL] [Abstract][Full Text] [Related]
10. A
Todd KL; Lai J; Sek K; Huang YK; Newman DM; Derrick EB; Koay HF; Nguyen D; Hoang TX; Petley EV; Chan CW; Munoz I; House IG; Lee JN; Kim JS; Li J; Tong J; N de Menezes M; Scheffler CM; Yap KM; Chen AXY; Dunbar PA; Haugen B; Parish IA; Johnstone RW; Darcy PK; Beavis PA
Nat Commun; 2023 Nov; 14(1):6990. PubMed ID: 37914685
[TBL] [Abstract][Full Text] [Related]
11. Functional Expression of Adenosine A
Jain AR; Robinson AS
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604732
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors.
Slaats J; Wagena E; Smits D; Berends AA; Peters E; Bakker GJ; van Erp M; Weigelin B; Adema GJ; Friedl P
Cancer Immunol Res; 2022 Dec; 10(12):1462-1474. PubMed ID: 36162129
[TBL] [Abstract][Full Text] [Related]
13. Homo-oligomerization of the human adenosine A
Nguyen KDQ; Vigers M; Sefah E; Seppälä S; Hoover JP; Schonenbach NS; Mertz B; O'Malley MA; Han S
Elife; 2021 Jul; 10():. PubMed ID: 34269678
[TBL] [Abstract][Full Text] [Related]
14. Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment.
Panetti S; McJannett N; Fultang L; Booth S; Gneo L; Scarpa U; Smith C; Vardon A; Vettore L; Whalley C; Pan Y; Várnai C; Endou H; Barlow J; Tennant D; Beggs A; Mussai F; De Santo C
Blood Adv; 2023 May; 7(9):1754-1761. PubMed ID: 36521029
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of adenosine on adaptive antitumor immunity and intervention strategies.
Wang L; Zhang W; Zhang J; Zheng M; Pan X; Guo H; Ding L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 52(5):567-577. PubMed ID: 37916308
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.
Renauer P; Park JJ; Bai M; Acosta A; Lee WH; Lin GH; Zhang Y; Dai X; Wang G; Errami Y; Wu T; Clark P; Ye L; Yang Q; Chen S
Cancer Immunol Res; 2023 Aug; 11(8):1068-1084. PubMed ID: 37253111
[TBL] [Abstract][Full Text] [Related]
17. Inosine induces stemness features in CAR-T cells and enhances potency.
Klysz DD; Fowler C; Malipatlolla M; Stuani L; Freitas KA; Chen Y; Meier S; Daniel B; Sandor K; Xu P; Huang J; Labanieh L; Keerthi V; Leruste A; Bashti M; Mata-Alcazar J; Gkitsas N; Guerrero JA; Fisher C; Patel S; Asano K; Patel S; Davis KL; Satpathy AT; Feldman SA; Sotillo E; Mackall CL
Cancer Cell; 2024 Feb; 42(2):266-282.e8. PubMed ID: 38278150
[TBL] [Abstract][Full Text] [Related]
18. Recent progress of gene circuit designs in immune cell therapies.
Lee S; Khalil AS; Wong WW
Cell Syst; 2022 Nov; 13(11):864-873. PubMed ID: 36395726
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function.
Renauer P; Park JJ; Bai M; Acosta A; Lee WH; Lin GH; Zhang Y; Dai X; Wang G; Errami Y; Wu T; Clark P; Ye L; Yang Q; Chen S
bioRxiv; 2023 Mar; ():. PubMed ID: 36993638
[TBL] [Abstract][Full Text] [Related]
20. Inosine Induces Stemness Features in CAR T cells and Enhances Potency.
Klysz DD; Fowler C; Malipatlolla M; Stuani L; Freitas KA; Meier S; Daniel B; Sandor K; Xu P; Huang J; Labanieh L; Leruste A; Bashti M; Keerthi V; Mata-Alcazar J; Gkitsas N; Guerrero JA; Fisher C; Patel S; Asano K; Patel S; Davis KL; Satpathy AT; Feldman SA; Sotillo E; Mackall CL
bioRxiv; 2023 Apr; ():. PubMed ID: 37162847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
